Lösch A, Tempfer C, Kohlberger P, Joura E A, Denk M, Zajic B, Breitenecker G, Kainz C
Gynaecopathological Unit, Institute of Pathology, University of Vienna, Austria.
Br J Cancer. 1998 Jul;78(2):205-9. doi: 10.1038/bjc.1998.465.
This study investigated the prognostic value of immunohistochemically detected cathepsin D expression in 103 invasive ductal carcinomas of the breast at stages pT1 and 2. We also assessed the association between cathepsin D expression and histomorphological tumour subtypes (invasive ductal carcinoma with extensive intraductal component, multifocal tumour). Cathepsin D expression was examined at two cut-off levels (positive and highly positive) and separately identified within the epithelial and stromal component of all tumours. Positive and highly positive epithelial expression was detected in 32 (31.1%) and 20 (19.4%) patients respectively. Stromal expression was found in 35 (34%) and 19 (18.4%) cases respectively. Epithelial cathepsin D expression was associated with stage and nuclear grade, but not with lymph node or oestrogen receptor status. Positive and highly positive epithelial cathepsin D expression showed significant prognostic value for overall survival (P = 0.003 and 0.01) and recurrence-free interval (P = 0.04 and 0.02). Cathepsin D expression in stromal cells was not associated with either several established prognostic factors or survival. Multivariate analysis revealed that cathepsin D expression failed to be an independent predictor of patients' outcome. Cathepsin D expression shows no significant association with histomorphological subtypes of breast cancer. Our study supports the prognostic impact of immunohistochemically detected cathepsin D expression in the epithelial component of breast cancer.
本研究调查了免疫组化检测组织蛋白酶D表达在103例pT1和2期乳腺浸润性导管癌中的预后价值。我们还评估了组织蛋白酶D表达与组织形态学肿瘤亚型(伴有广泛导管内成分的浸润性导管癌、多灶性肿瘤)之间的关联。在两个临界水平(阳性和强阳性)检测组织蛋白酶D表达,并在所有肿瘤的上皮和间质成分中分别进行鉴定。分别在32例(31.1%)和20例(19.4%)患者中检测到上皮阳性和强阳性表达。间质表达分别见于35例(34%)和19例(18.4%)。上皮组织蛋白酶D表达与分期和核分级相关,但与淋巴结或雌激素受体状态无关。上皮组织蛋白酶D阳性和强阳性表达对总生存期(P = 0.003和0.01)和无复发生存期(P = 0.04和0.02)显示出显著的预后价值。间质细胞中的组织蛋白酶D表达与几种既定的预后因素或生存期均无关联。多变量分析显示,组织蛋白酶D表达未能成为患者预后的独立预测指标。组织蛋白酶D表达与乳腺癌的组织形态学亚型无显著关联。我们的研究支持免疫组化检测组织蛋白酶D表达在乳腺癌上皮成分中的预后影响。